Dr. Sahdeo Prasad

Dr. Sahdeo Prasad obtained his Ph.D. (Biotechnology) from the Indian Institute of Toxicology Research (CSIR), Lucknow, India. Currently, he is working as a Principal Scientist at R&D Life Sciences, Florida. Before joining this University, Dr. Prasad served as a scientist at the Masonic Cancer Center, University of Minnesota, Principal Scientist in Nobel Pharma, Wisconsin, and Research Instructor at Texas Tech University. During his doctoral research program, he extensively worked on cancer prevention and therapy using signal transduction pathways in both in vivo and in vitro tumor models. After completion of his PhD program, he worked as a Post-Doctoral Fellow at the University of Texas MD Anderson Cancer Center. His expertise is in the area of molecular biology, with particular reference to the molecular mechanisms of signal transduction in tumor cells. Dr. Prasad has discovered a number of phytochemicals with chemo-preventive effects against a variety of cancers and their mechanism of action by targeting transcription factors, kinases, and oncogenes. Besides these, Dr. Prasad’s work is also focused on the effect of natural compounds on death receptor pathways, bone loss, and the chemosensitization of tumor cells. He has numerous national and international publications and abstracts indexed in international conferences. He is also an editorial board member of various reputed journals and a member of various scientific societies.